Veracyte, Inc.
VCYT
$58.83
$2.073.65%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.11% | 6.65% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.11% | 6.65% | |||
| Cost of Revenue | -22.38% | 30.31% | |||
| Gross Profit | 9.01% | -1.84% | |||
| SG&A Expenses | 9.35% | -14.92% | |||
| Depreciation & Amortization | -1.29% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.35% | 6.68% | |||
| Operating Income | -7.99% | 6.49% | |||
| Income Before Tax | -26.23% | 115.12% | |||
| Income Tax Expenses | 346.02% | -107.66% | |||
| Earnings from Continuing Operations | -30.24% | 115.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.24% | 115.02% | |||
| EBIT | -7.99% | 6.49% | |||
| EBITDA | -6.13% | 5.40% | |||
| EPS Basic | -30.56% | 113.78% | |||
| Normalized Basic EPS | 6.37% | 8.26% | |||
| EPS Diluted | -29.65% | 107.29% | |||
| Normalized Diluted EPS | 6.96% | 6.58% | |||
| Average Basic Shares Outstanding | 0.45% | 0.58% | |||
| Average Diluted Shares Outstanding | -0.09% | 2.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||